|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase III | Marketed |
|---|
| Autoimmune | 1 | 0 | 0 | 0 | 0 | | Cancer | 1 | 0 | 0 | 0 | 0 | | Dermatology | 1 | 0 | 0 | 0 | 0 | | Gastrointestinal | 0 | 0 | 0 | 3 | 2 | | Infectious | 1 | 0 | 0 | 0 | 0 | | Neurology | 0 | 2 | 2 | 0 | 0 | | Other | 1 | 0 | 0 | 0 | 0 | | Pulmonary | 1 | 1 | 0 | 0 | 0 |
|
|
Products Targeting Neurokinin 1 (NK1) Substance P receptor (TACR1)